DDrare: Database of Drug Development for Rare Diseases

16. クロウ・深瀬症候群
［臨床試験数：12，薬物数：18（DrugBank：8），標的遺伝子数：5，標的パスウェイ数：79］

Searched query = "Crow-Fukase syndrome", "POEMS syndrome", "Polyneuropathy, organomegaly, endocrinopathy, m-protein, and skin changes syndrome", "Takatsuki disease", "PEP syndrome", "Polyneuropathy, endocrinopathy, plasma cell dyscrasia syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Cyclophosphamide; Daratumumab; Daratumumab Injection; Dexamethasone; FPF 300 (thalidomide); G-CSF; Ixazomib; Ixazomib Citrate; Lenalidomide; Lenalidomide and dexamethasone; Lenalidomide+Dexamethasone; Lenalidomide, Dexamethasone; Lenograstim; Other: Laboratory Biomarker Analysis; Other: Questionnaire Administration; REVLIMID*21CPS 25MG; Revlimid; Thalidomide

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-003202-33-IT (EUCTR)	15/09/2009	17/11/2009	Evaluation of efficacy and safety of Lenalidomide (Revlimid) in patients with POEMS Syndrome - ONC-2008-002	Evaluation of efficacy and safety of Lenalidomide (Revlimid) in patients with POEMS Syndrome - ONC-2008-002	POEMS SYNDROME MedDRA version: 9.1;Level: SOC;Classification code 10029205	Trade Name: REVLIMID *21CPS 25MG INN or Proposed INN: Lenalidomide	ISTITUTO CLINICO HUMANITAS	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

EUCTR2008-003202-33-IT
(EUCTR)

15/09/2009

17/11/2009

Evaluation of efficacy and safety of Lenalidomide (Revlimid) in patients with POEMS Syndrome - ONC-2008-002

POEMS SYNDROME
MedDRA version: 9.1;Level: SOC;Classification code 10029205

Trade Name: REVLIMID *21CPS 25MG
INN or Proposed INN: Lenalidomide

ISTITUTO CLINICO HUMANITAS

NULL

Authorised-recruitment may be ongoing or finished

Female: yes
Male: yes

Italy